Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68Ga-JH04 PET/CT in various cancers
NCT06455735Phase 1Recruiting
- Sponsor
- The First Hospital of Fujian Medical University
- Start
- Mar 2024
- Primary completion
- Dec 2025
- Modality
- Peptide-Drug Conjugates
- Countries
- 1
01
Overview
Phase 1, open-label trial of 68Ga-JH04 in solid tumor (2 arms), sponsored by The First Hospital of Fujian Medical University. Primary endpoint: Diagnostic value at 3 months. Started Mar 2024; status: recruiting.
02
Drugs
68Ga-JH04
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT06455735.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06455735.